solid tumorsKSQ-004EXNCT06598371Tumor Infiltrating Lymphocyte (TIL) therapytumor
…trating Lymphocyte (TIL) therapy is an autologous treatment for solid tumors involving isolation and ex vivo expansion of polyclonal T lymph…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 340 of 2459RD213cold tumorsAdoptive cell therapysolid tumor typesNOG micesolid tumors
…e treatment of refractory solid tumors. Clinical development of RD213 is currently underway.…
myelomaleukemialymphomanonmelanoma skin cancerAMLCAR-T therapyMDShematologic malignanciesCochrane CENTRALsolid tumors+2 more
…ollowing CAR-T therapy in patients with leukemia, lymphoma, and myeloma.Methods MEDLINE, Embase, Web of Science, and Cochrane CENTRAL d…
nivolumabipilimumabmelanoma
… the incidence and severity of irAEs in melanoma patients using nivolumab, along with the management and outcomes of irAEs, and the overa…
AbbVieICIcolorectal tumorsmouse tumor modelanti-CD40 agonist antibodyhuman cancer typesT cell exhaustion
…c efficacy of immunotherapy.Ethics Approval Ethics committee of AbbVie gave ethical approval for this work.…
immunotherapyEinstein IRBCPAHepatocellular carcinomaHCC
…identify patients who are likely to have meaningful survival on immunotherapy.Ethics Approval The IRB protocol was approved by Einstein IRB.…
Hodgkin lymphomalung cancermelanomastomach cancerdiffuse large B-cell lymphomafollicular lymphomacolon cancergliomaIFN-ICOVID-19
…ffuse large B-cell lymphoma, n=249; follicular lymphoma, n=107; Hodgkin lymphoma, n=96, stomach cancer, n=90; lung cancer, n=49; others, n=196).…
pembrolizumabUniversity of Southern CaliforniaUniversity of Florida College of MedicineWashington UniversityUniversity of Southern California Keck School of MedicineWashington University in St. Louis School of MedicineUniversity of FloridaIDH-wildtype glioblastomarHGALaser interstitial thermal therapy
…LITT+PEM) or non-LITT surgery (biopsy or resection) followed by pembrolizumab (NLS+PEM). After 21 patients, randomization was halted when eme…
atezolizumabmFOLFOX6ATOMICStage III colon cancers
…mFOLFOX6 plus atezolizumab 840 mg Q2W for 12 cycles followed by atezolizumab monotherapy Q3W for 13 cycles (experimental). The primary end-p…
evorpaceptlenalidomiderituximabB-cell non-hodgkin lymphomaB-NHLNCT05025800Clin Cancer ResALX148
…erence Strati P, Feng L, Tyshevich A, et al. A phase I trial of evorpacept, lenalidomide, and rituximab for patients with B-cell non-hodgk…
Chulalongkorn UniversitydexamethasoneCMD03anakinraB7-H3Diffuse intrinsic pontine glioma (DIPG)B7-H3-targetingDIPGCancer Immunol Immunother
…DIPG ( NCT06221553). Approval was granted by the IRB committee, Chulalongkorn University (COA#1647/2024). Dose levels include 1×107, 3×107, and 1×108 CA…
HNSCCimmunotherapyMount Sinai Institutional BiorepositoryHead and neck squamous cell carcinoma (HNSCC)Mount Sinai PPHS IRB
…unique samples. Compared to HPV+ oropharynx tumors, oral cavity HNSCC had significantly higher proportions of NK cells (p = 0.02), an…